Skip to main content

and
  1. Article

    Open Access

    Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit Analysis

    Low-calorie diets, high in protein and low in carbohydrates, are commonly recommended for patients with pre-diabetes and type 2 diabetes. The objective of this study was to carry out a cost-benefit analysis (C...

    Saud Al Sifri, Raed Aldahash, Daniel-Antonio de Luis Roman, Ahmed Amin in Diabetes Therapy (2024)

  2. Article

    Open Access

    A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System

    Accumulating evidence suggests that oral supplementation with myo-Inositol (myo-Ins) is able to reduce the amount of gonadotropins and days of controlled ovarian hyperstimulation (COS) necessary to achieve ade...

    Ariel Beresniak, Michele Russo, Gianpiero Forte in Scientific Reports (2023)

  3. Article

    Open Access

    The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?

    The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures ag...

    Ariel Beresniak, Christian Napoli in Cost Effectiveness and Resource Allocation (2023)

  4. No Access

    Chapter

    The ASSET Research Project as a Tool for Increased Levels of Preparedness and Response to Public Health Emergencies

    Epidemics and pandemics are natural events recurring over the time: their impact can be appropriately minimised but most countries only rely on emergency response. The European Decision 1082/2013 on serious cr...

    Valentina Possenti, Barbara De Mei in Responsible Research and Innovation Action… (2018)

  5. No Access

    Article

    Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project

    Quality-adjusted life-years (QALYs) have been used since the 1980s as a standard health outcome measure for conducting cost-utility analyses, which are often inadequately labeled as ‘cost-effectiveness analyse...

    Ariel Beresniak, Antonieta Medina-Lara, Jean Paul Auray in PharmacoEconomics (2015)

  6. No Access

    Article

    Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis

    To assess the cost-effectiveness of abatacept compared to different biologic treatment strategies for moderate to severe rheumatoid arthritis based on current medical practices in Canada. A model was construct...

    Anthony Russell, Ariel Beresniak, Louis Bessette, Boulos Haraoui in Clinical Rheumatology (2009)

  7. No Access

    Article

    Testing assumptions of quality-adjusted life-year calculations

    Ariel Béresniak in The European Journal of Health Economics, formerly: HEPAC (2003)

  8. No Access

    Article

    Cost-Effectiveness of Recombinant Versus Urinary Follicle-Stimulating Hormone in Assisted Reproduction Techniques in the Spanish Public Health Care System

    Purpose : To evaluate the relative cost-effectiveness of recombinant and urinary follicle-stimulating hormone (FSH) in assisted reproduction techniques in the Spanish National Health Service.

    Alberto Romeu, Juan Balasch in Journal of Assisted Reproduction and Genet… (2003)

  9. No Access

    Article

    Limitations of the Methods Used for Calculating Quality-Adjusted Life-Year Values

    Objective: To test the validity of the techniques used to calculate quality-adjusted life-year (QALY) values based on utility functions, using a real population dataset.

    Gérard Duru, Jean Paul Auray, Ariel Béresniak, Michel Lamure in PharmacoEconomics (2002)